atropine has been researched along with clindamycin in 16 studies
Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (clindamycin) | Trials (clindamycin) | Recent Studies (post-2010) (clindamycin) |
---|---|---|---|---|---|
26,711 | 1,259 | 1,697 | 6,297 | 892 | 1,636 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (37.50) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (37.50) | 29.6817 |
2010's | 4 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Levine, B; Peskin, GW; Saik, RP | 1 |
Pittman, FE | 1 |
Konopka, LM; Parsons, RL | 1 |
Fogdall, RP; Miller, RD | 1 |
Aratani, H; Kono, S; Onishi, R; Tateishi, H; Yamanaka, Y | 1 |
Canapp, SO; Cohn, LA; Kerl, ME; Maggs, DJ; Miller, MA; O'Brien, DP | 1 |
1 review(s) available for atropine and clindamycin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for atropine and clindamycin
Article | Year |
---|---|
Letter: Clindamycin and colitis.
Topics: Antidiarrheals; Atropine; Clindamycin; Clinical Trials as Topic; Colitis; Drug Combinations; Humans; Isonipecotic Acids; Placebos | 1975 |
14 other study(ies) available for atropine and clindamycin
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Drug-induced colitis as a surgical disease.
Topics: Adrenal Cortex Hormones; Aged; Ampicillin; Atropine; Clindamycin; Colectomy; Colon; Diphenoxylate; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged | 1976 |
Letter: Lomotil and antibiotic colitis.
Topics: Aged; Atropine; Clindamycin; Colitis; Diarrhea; Diphenoxylate; Drug Combinations; Female; Gastrointestinal Agents; Humans; Lincomycin | 1975 |
Clindamycin-induced alteration of ganglionic function. I. Direct effects on ganglion cell properties.
Topics: Action Potentials; Animals; Atropine; Calcium; Clindamycin; Ganglia, Sympathetic; In Vitro Techniques; Membrane Potentials; Neurons; Rana catesbeiana; Reference Values; Tetrodotoxin; Tubocurarine | 1988 |
Prolongation of a pancuronium-induced neuromuscular blockade by clindamycin.
Topics: Atropine; Clindamycin; Drug Synergism; Female; Humans; Infusions, Parenteral; Middle Aged; Neostigmine; Neuromuscular Junction; Pancuronium | 1974 |
[Pharmacological studies on clindamycin-2-palmitate (author's transl)].
Topics: Acetylcholine; Animals; Anura; Atropine; Barium; Blood Vessels; Bronchi; Capillary Permeability; Clindamycin; Drug Evaluation, Preclinical; Female; Guinea Pigs; Heart; Heart Atria; Histamine; In Vitro Techniques; Intestines; Lincomycin; Male; Palmitic Acids; Potassium; Pregnancy; Rabbits; Rats; Sodium; Uterus | 1973 |
Xerostomia, xerophthalmia, and plasmacytic infiltrates of the salivary glands (Sjögren's-like syndrome) in a cat.
Topics: Animals; Anti-Bacterial Agents; Atropine; Biopsy; Cat Diseases; Cats; Clindamycin; Cornea; Deglutition Disorders; Female; Glucocorticoids; Miotics; Mydriatics; Pilocarpine; Prednisone; Salivary Glands; Sjogren's Syndrome; Tears; Videotape Recording; Xerophthalmia; Xerostomia | 2001 |